Abstract
Septic arthritis is an infectious disease emergency, requiring aggressive joint drainage and prompt antibiotic therapy. Because age and joint damage are major risk factors, septic arthritis may become more common as the baby-boom generation reaches senescence. Bacteremic joint infections have a high mortality, and long-term disability from joint damage is common. Lyme arthritis has a negligible mortality and low morbidity but causes disproportionate popular anxiety. Most patients with Lyme arthritis respond well to oral antibiotic regimens and recover completely. A few patients develop antibiotic-resistant Lyme arthritis, which is probably autoimmune in nature and responds to immunosuppressive therapy. This paper reviews the presentation, diagnosis, and management of bacterial and Lyme arthritis. Septic arthritis caused by Streptococcus pneumoniae and group B streptococci may be increasing in prevalence. Prospective studies are required to determine whether there is any benefit of surgical or arthroscopic joint drainage in septic arthritis, compared with serial arthrocentesis, and to determine the role of corticosteroid therapy in septic arthritis in adults, if any.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References and Recommended Reading
Goldenberg DL, Reed JI: Bacterial arthritis. N Engl J Med 1985, 312:764–771.
Kaandorp CJ, Dinant HJ, van de Laar MA, et al.: Incidence and sources of native and prosthetic joint infection: a community based prospective survey. Ann Rheum Dis 1997, 56:470–475.
Haug JB, Harthug S, Kalager T, et al.: Bloodstream infections at a Norwegian university hospital, 1974–1979 and 1988–89: changing etiology, clinical features, and outcome. Clin Infect Dis 1994, 19:246–256.
Ross JJ, Saltzman CL, Carling P, Shapiro DS: Pneumococcal septic arthritis: review of 190 cases. Clin Infect Dis 2003, 36:319–327. This is a verbose but complete review. Pneumococcal septic arthritis is increasingly troublesome in regard to antibiotic resistance and may be becoming more prevalent.
Patti JM, Bremell T, Krajewska-Pietrasik D, et al.: The Staphylococcus aureus collagen adhesin is a virulence determinant in experimental septic arthritis. Infect Immun 1994, 62:152–161.
Shirtliff ME, Mader JT: Acute septic arthritis. Clin Microbiol Rev 2002, 15:527–544. This is a good recent review of septic arthritis from a basic science and microbiology perspective.
Stevens CR, Williams RB, Farrell AJ, Blake DR: Hypoxia and inflammatory synovitis: observations and speculation. Ann Rheum Dis 1991, 50:124–132.
Gardner GC, Weisman MH: Pyarthrosis in patients with rheumatoid arthritis: a report of 13 cases and a review of the literature from the past 40 years. Am J Med 1990, 88:503–511.
Blackburn WD, Dunn TL, Alarcón GS: Infection versus disease activity in rheumatoid arthritis: eight years’ experience. South Med J 1986, 79:1238–1241.
Ilahi OA, Swarna U, Hamill RJ, et al.: Concomitant crystal and septic arthritis. Orthopedics 1996, 19:613–617.
Baghai M, Osmon DR, Wolk DM, et al.: Fatal sepsis in a patient with rheumatoid arthritis treated with etanercept. Mayo Clin Proc 2001, 76:653–656.
Weston VC, Jones AC, Bradbury N, et al.: Clinical features and outcome of septic arthritis in a single UK Health District 1982–1991. Ann Rheum Dis 1999, 58:214–219. This is one of the largest recent studies of septic arthritis cases. Mortality and morbidity were high, despite appropriate therapy in most patients.
Goldenberg DL, Cohen AS: Acute infectious arthritis. Am J Med 1976, 60:369–377.
Edwards SA, Cranfield T, Clarke HJ: Atypical presentation of septic arthritis in the immunosuppressed patient. Orthopedics 2002, 25:1089–1090.
Jones A, Doherty M: ABC of rheumatology: osteoarthritis. BMJ 1995, 310:457–460.
Brancós MA, Peris P, Miró JM, et al.: Septic arthritis in heroin addicts. Semin Arthritis Rheum 1991, 21:81–87.
Dubost JJ, Fis I, Denis P, et al.: Polyarticular septic arthritis. Medicine (Baltimore) 1993, 72:296–310.
Sharp JT, Lidsky MD, Duffy J, Duncan MW: Infectious arthritis. Arch Intern Med 1979, 139:1125–1130.
Bremell T, Tarkowski A: Preferential induction of septic arthritis and mortality by superantigen-producing staphylococci. Infect Immun 1995, 63:4185–4187.
Farley MM: Group B streptococcal disease in nonpregnant adults. Clin Infect Dis 2001, 33:556–561.
Dubost JJ, Saubrier M, De Champs C, et al.: No changes in the distribution of organisms responsible for septic arthritis over a 20 year period. Ann Rheum Dis 2002, 61:267–269.
Nolla JM, Gómez-Vaquero C, Corbella X, et al.: Group B Streptococcus (Streptococcus agalactiae) pyogenic arthritis in nonpregnant adults. Medicine (Baltimore) 2003, 82:119–127. This paper reviews the clinical features of septic arthritis caused by the group B Streptococcus, an emerging pathogen in the elderly and immunocompromised.
Ryan MJ, Kavanagh R, Wall PG, Hazleman BL: Bacterial joint infections for England and Wales: analysis of bacterial isolates over a four year period. Br J Rheumatol 1997, 36:370–373.
Ispahani P, Weston VC, Turner DPJ, Donald FE: Septic arthritis due to Streptococcus pneumoniae in Nottingham, United Kingdom, 1985–1998. Clin Infect Dis 1999, 29:1450–1454.
Centers for Disease Control and Prevention: Gonorrhea—United States, 1998. MMWR Morb Mortal Wkly Rep 2000, 49:538–542.
O’Brien JP, Goldenberg DL, Rice PA: Disseminated gonococcal infection: a prospective analysis of 49 patients and a review of pathophysiology and immune mechanisms. Medicine (Baltimore) 1983, 62:395–406.
Goldenberg DL, Brandt KD, Cathcart ES, Cohen AS: Acute arthritis due to Gram-negative bacilli: a clinical characterization. Medicine (Baltimore) 1974, 53:197–208.
Bayer AS, Chow AW, Louie J, et al.: Gram-negative bacillary septic arthritis: clinical, radiographic, therapeutic, and prognostic features. Semin Arthritis Rheum 1977, 7:123–132.
Newman ED, Davis DE, Harrington TM: Septic arthritis due to Gram negative bacilli: older patients with good outcome. J Rheumatol 1988, 15:659–662.
Lee SH, Abramson SB: Infections of the musculoskeletal system by M. tuberculosis. In Tuberculosis. Edited by Rom WN, Garay SM. Boston: Little, Brown and Company; 1996:635–644.
Gotuzzo E, Alarcon GS, Bocanegra TS, et al.: Articular involvement in human brucellosis: a retrospective analysis of 304 cases. Semin Arthritis Rheum 1982, 12:245–255.
Baum C, Hsu JP, Nelson RC: The impact of the addition of naloxone on the use and abuse of pentazocine. Public Health Rep 1987, 102:426–429.
Darke S, Kaye S, Ross J: Geographic injecting locations among injecting drug users in Sydney, Australia. Addiction 2001, 96:241–246.
Tuazon CU, Sheagren JN: Increased rate of carriage of Staphylococcus aureus among narcotic addicts. J Infect Dis 1974, 129:725–727.
Ross JJ, Hu LT: Septic arthritis of the pubic symphysis: review of 100 cases. Medicine (Baltimore) 2003, 82:340–345.
Ross JJ, Shamsuddin H: Sternoclavicular septic arthritis: review of 180 cases. Medicine (Baltimore) 2004, 83:139–148.
Krogstad P, Smith AL: Osteomyelitis and septic arthritis. In Textbook of Pediatric Infectious Disease, edn 4. Edited by Feigin RD, Cherry JD. Philadelphia: WB Saunders; 1998:683–704.
Luhmann JD, Luhmann SJ: Etiology of septic arthritis in children: an update for the 1990s. Pediatr Emerg Care 1999, 15:40–42.
Zimmerli W: Prosthetic joint infection: diagnosis and treatment. Curr Infect Dis Rep 2000, 2:377–379.
Fye KH: Arthrocentesis, synovial fluid analysis, and synovial biopsy. In Primer on the Rheumatic Diseases, edn 12. Edited by Klippel JH. Atlanta: Arthritis Foundation; 2001:138–144.
McCutchan HJ, Fisher RC: Synovial leukocytosis in infectious arthritis. Clin Orthop Rel Res 1990, 257:226–230.
Shmerling RH, Delbanco TL, Tosteson AN, Trentham DE:Synovial fluid tests. What should be ordered? JAMA 1990, 264:1009–1014.
Cooper C, Cawley MI: Bacterial arthritis in an English health district: a 10 year review. Ann Rheum Dis 1986, 45:458–463.
Hepburn MJ, Fraser SL, Rennie TA, et al.: Septic arthritis caused by Granulicatella adiacens: diagnosis by inoculation of synovial fluid into blood culture bottles. Rheumatol Int 2003, 23:255–257.
Fass RJ: Treatment of osteomyelitis and septic arthritis with cefazolin. Antimicrob Agents Chemother 1978, 13:405–411.
Salgado CD, Farr BM, Calfee DP: Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis 2003, 36:131–139.
Naimi TS, LeDell KH, Como-Sabetti K, et al.: Comparison of community-acquired and health-care associated methicillinresistant Staphylococcus aureus infection. JAMA 2003, 290:2976–2984.
Howden BP, Ward PB, Charles PG, et al.: Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility. Clin Infect Dis 2004, 38:521–528.
Pioro MH, Mandell BF: Septic arthritis. Rheum Dis Clin North Am 1997, 23:239–258.
Smith JW, Piercy EA: Infectious arthritis. Clin Infect Dis 1995, 20:225–231.
Broy SB, Schmid FR: A comparison of medical drainage (needle aspiration) and surgical drainage (arthrotomy or arthroscopy) in the initial treatment of infected joints. Clin Rheum Dis 1986, 12:501–522.
Odio CM, Ramirez T, Arias G, et al.: Double blind, randomized, placebo-controlled study of dexamethasone therapy for hematogenous septic arthritis in children. Pediatr Infect Dis J 2003, 22:883–889.
Salter RB: The biologic concept of continuous passive motion of synovial joints: the first 18 years of research and its clinical application. Clin Orthop 1989, 242:12–25.
Steere AC: Lyme disease. N Engl J Med 2001, 345:115–125. This overview is authoritative and comprehensive.
Leong JM, Robbins D, Rosenfeld L, et al.: Structural requirements for glycosaminoglycan recognition by the Lyme disease spirochete, Borrelia burgdorferi. Infect Immun 1998, 66:6045–6048.
Leong JM, Wang H, Magoun L, et al.: Different classes of proteoglycans contribute to the attachment of Borrelia burgdorferi to cultured endothelial and brain cells. Infect Immun 1998, 66:994–999.
Klempner MS, Noring R, Epstein MP, et al.: Binding of human plasminogen and urokinase-type plasminogen activator to the Lyme disease spirochete, Borrelia burgdorferi. J Infect Dis 1995, 171:1258–1265.
Coleman JL, Sellati TJ, Testa JE, et al.: Borrelia burgdorferi binds plasminogen, resulting in enhanced penetration of endothelial monolayers. Infect Immun 1995, 63:2478–2484.
Steere AC, Duray PH, Butcher EC: Spirochetal antigens and lymphoid cell surface markers in Lyme synovitis: comparison with rheumatoid synovium and tonsillar lymphoid tissue. Arthritis Rheum 1988, 31:487–495.
Lin B, Kidder JM, Noring R, et al.: Differences in synovial fluid levels of matrix metalloproteinases suggest separate mechanisms of pathogenesis in Lyme arthritis before and after antibiotic treatment. J Infect Dis 2001, 184:174–180.
Kalish RA, Leong JM, Steere AC: Association of treatmentresistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi. Infect Immun 1993, 61:2774–2779.
Gross DM, Forsthuber T, Tary-Lehmann M, et al.: Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science 1998, 281:703–706.
Wang G, Ojaimi C, Wu H, et al.: Disease severity in a murine model of lyme borreliosis is associated with the genotype of the infecting Borrelia burgdorferi sensu stricto strain. J Infect Dis 2002, 186:782–791.
Steere AC, Craft JE, Hutchinson GJ, et al.: The early clinical manifestations of Lyme disease. Ann Intern Med 1983, 99:76–82.
Steere AC, Schoen RT, Taylor E: The clinical evolution of Lyme arthritis. Ann Intern Med 1987, 107:725–731.
Zhang JR, Norris SJ: Genetic variation of the Borrelia burgdorferi gene vlsE involves cassette-specific, segmental gene conversion. Infect Immun 1998, 66:3698–3704.
Zhang JR, Hardham JM, Barbour AG, Norris SJ: Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes. Cell 1997, 89:275–285.
Hu LT, Klempner MS: Update on the prevention, diagnosis, and treatment of Lyme disease. Adv Intern Med 2001, 46:247–275.
Wormser GP, Nadelman RB, Dattwyler RJ, et al.: Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America. Clin Infect Dis 2000, 31:S1-S14. This set of treatment guidelines is based on a thorough review of the relevant literature.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ross, J.J., Hu, L.T. Bacterial and lyme arthritis. Curr Infect Dis Rep 6, 380–387 (2004). https://doi.org/10.1007/s11908-004-0037-y
Issue Date:
DOI: https://doi.org/10.1007/s11908-004-0037-y